 |
|
Spring Meeting Trial Reports:
2011 /
2010 /
2009
|
| ID |
Study Title |
Status |
|
IND.169 |
This is a Non-Randomized, Non-Blinded Multicentre Phase II Study of SB-715992 in Previously
Untreated Patients with Metastatic or Recurrent Malignant Melanoma
MORE... |
Permanently Closed |
|
IND.189 |
A Phase II Study of Interlukin-21 (Il-21) in Patients with Metastatic or Recurrent Malignant
Melanoma
MORE... |
Closed |
|
IND.202 |
A Randomized Phase II Study of Interleukin-21 (rIL-21) versus Dacarbazine (DTIC) in
Patients with Metastatic or Recurrent Melanoma
MORE... |
Open |
ME.10
ECOG R1697 |
Phase III Randomized Study of Four Weeks High Dose IFN-ALPHA2b IN Stage T2bNo, T3a-bNo, T4a-bNo, and T1-4, N1a,2a,3
(microscopic) Melanoma
MORE... |
Closed |
